Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation

v3.25.1
Stock-Based Compensation
3 Months Ended
Mar. 30, 2025
Stock-Based Compensation  
Stock-Based Compensation and Warrants

Note 14 – Stock-Based Compensation

As of March 30, 2025, the Company had 1,941,354 shares available for issuance under its 2019 Equity Incentive Plan (the “2019 Equity Plan”).

Stock-based compensation cost for the three periods ended March 30, 2025 and the three months ended March 31, 2024 was $1.6 million and $1.4 million, respectively. Stock-based compensation is included in general and administrative expenses in the condensed consolidated statements of operations. Included in stock-based compensation cost for the three periods ended March 30, 2025 and three months ended March 31, 2024, was $0.2 million and $0.1 million, respectively, of cost related to unrestricted stock granted to directors. Such grants were awarded consistent with the Board of Director’s compensation practices. Stock-based compensation for both the three periods ended March 30, 2025 and the three months ended March 31, 2024 included $0.2 million of compensation costs for performance stock units that contain both a market condition and time element (“PSUs”).

Stock Option Activity

Stock options in the table below include both time-based and market condition-based awards. Changes in stock options during the three periods ended March 30, 2025 were as follows:

Weighted

Weighted

average

Intrinsic

average exercise

remaining

value

    

Shares

    

price

    

contractual life

    

(thousands)

Outstanding at December 31, 2024

 

838,284

$

3.11

 

4.72 years

$

567

Granted

 

 

  

 

  

Exercised

 

 

  

 

  

Cancelled, expired or forfeited

 

(9,356)

5.73

 

 

  

Outstanding at March 30, 2025

 

828,928

$

3.08

 

4.43 years

$

613

Exercisable at March 30, 2025

578,942

$

1.93

2.44 years

$

613

A summary of the status of the Company’s non-vested stock options during the three periods ended March 30, 2025 is presented below:

Weighted average

    

Shares

    

grant date fair value

Non-vested stock options at December 31, 2024

 

259,342

$

3.67

Granted

 

Vested

 

Cancelled, expired or forfeited

 

(9,356)

3.67

Non-vested stock options at March 30, 2025

 

249,986

$

3.67

Restricted Stock Unit Activity

The Company issues restricted stock units (“RSUs”) under the 2019 Equity Plan. RSUs in the table below include time-based awards. The fair value of time-based RSUs is determined based upon the closing market value of the Company’s common stock on the grant date.

A summary of the status of RSUs and changes during the three periods ended March 30, 2025 is presented below:

Weighted average

    

Shares

    

grant date fair value

Non-vested RSUs at December 31, 2024

 

973,100

$

6.66

Granted

 

718,689

 

2.98

Vested

 

(96,273)

 

9.31

Cancelled, expired or forfeited

 

(26,016)

 

5.90

Non-vested RSUs at March 30, 2025

 

1,569,500

$

4.82

As of March 30, 2025, the Company had approximately $5.7 million of unrecognized compensation costs related to RSUs, which will be recognized over a weighted average period of 2.0 years.

Performance Stock Unit Activity

The Company issues performance stock units (“PSUs”) under the 2019 Equity Plan. PSUs in the table below includes both time based and market condition-based awards and are valued using the Monte Carlo Simulation.

A summary of the status of PSUs and changes during the three periods ended March 30, 2025 is presented below:

Weighted average

    

Shares

    

grant date fair value

Non-vested PSUs at December 31, 2024

 

473,166

$

5.63

Granted

 

118,367

 

2.49

Vested

 

 

Cancelled, expired or forfeited

 

 

Non-vested PSUs at March 30, 2025

 

591,533

$

5.00

As of March 30, 2025, the Company had approximately $1.6 million of unrecognized compensation costs related to PSUs, which will be recognized over a weighted average period of 1.8 years.